Beijing CorreGene Biotechnology Co., Ltd.

Private

BeijingHealthcare & Life Scienceshttps://corregene.com/

Last Round

VC Round

Nov 1, 2022

Total Funding Raised

$3.08M

Company Overview

Beijing CorreGene Biotechnology Co., Ltd. is a biotechnology company that develops innovative therapeutics based on T-cell receptors (TCRs) for the treatment of tumors, chronic infections, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

TCR therapyTCR-T cell therapycell therapyimmunotherapyimmuno-oncologyTCR bispecific antibodysolid tumor treatmentintracellular antigen targetinggene therapyKRAS mutation targetingcell and gene therapyCGTundruggable target therapydrug discovery platformclinical-stage biotechAI-assisted drug designAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing CorreGene Biotechnology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Beijing CorreGene Biotechnology Co., Ltd. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beijing CorreGene Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Nov 1, 2022
VC Round	Nov 1, 2021
Angel	Dec 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Dong Jiang

CTO

Executive Team

Beijing CorreGene Biotechnology Co., Ltd. Investors

Notable investors and investment history

Beijing CorreGene Biotechnology Co., Ltd. investors
Investor	Rounds
Anlong Fund	Angel

View all Investors

Beijing CorreGene Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Beijing CorreGene Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing CorreGene Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Employee Range27

Year Founded2016

Last FundingNov 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.